Strategic Investment in Sigma Healthcare
![](/sites/hmc/assets/sigma-logo.png)
HMC Capital Partners Fund 1 holds a strategic stake in Sigma Healthcare Limited (ASX:SIG), a leading Australian full line wholesale and distribution business to community pharmacy.
During the period of its investment, the Fund has supported Sigma in relation to a number of value enhancing initiatives, including successfully winning a material supply contract to Chemist Warehouse Group and the proposed transformational merger with Chemist Warehouse Group announced in December 2023.
View the Sigma Healthcare case study
Strategic Investment in Lendlease
![](/sites/hmc/assets/Lendlease-Logo.png)
HMC Capital Partners Fund 1 holds a strategic stake in Lendlease Group (ASX:LLC), an Australian real estate construction, development and investment management company.
Lendlease is currently executing a strategic transition to a more focused, simplified structure which is planned to include the release of A$4.5bn of capital back to the balance sheet. This strategy is in line with the recommendations the Fund set out in its paper released in August 2023.
View the Lendlease presentation
HMC Capital Partners Fund I (Fund), is an Australian-domiciled unlisted fund providing exposure to a high-conviction investment strategy seeking to generate superior risk-adjusted returns.
The Fund will target public and private companies with real asset backing where there is potential to unlock ‘trapped’ value through improved capital allocation and portfolio management.
The Fund is managed by the same team which led the real estate acquisition of Masters from Woolworths Limited in 2017 and who founded HMC Capital, complemented by additional dedicated and high calibre investment professionals.
This Fund will target our highest conviction ideas and leverage our proven investment track record and skills to generate attractive risk adjusted returns which are non-correlated to equity markets over the long-term
Key Fund Features
Feature | Detail |
---|---|
Fund Inception | 31 August 2022 |
Unit Pricing Frequency | Monthly |
Target Return1 | 15%+ net IRR per annum measured over a 3 to 5 year holding period. |
Target Distribution Yield1 | 2 to 4% per annum (post the second anniversary of First Close). |
Manager Participation | HMC Capital has invested $170 million into the Fund. |
Portfolio Positions | Up to 10 positions in listed investments2 |
Available to: | Investors who meet the definition of a wholesale investor and who have a minimum investment amount of $50,000 |
Fees | Management fee: 1.0% p.a. of NAV Performance fee: 20% performance fee above 7% p.a. hurdle rate subject to a high-water mark. |
Applications | Monthly applications with instructions to be sent through 10 business days before month end. |
Redemptions | Quarterly on the last business day of Mar, Jun, Sept, and Dec with 90 days' prior notice. Redemptions will be subject to a limit of 5% of the fund units outstanding at the end of each quarter. |
- Target Return and Target Distribution Yield are net of base management fees and costs but before tax (if applicable) and performance fees. This is only a target and may not be achieved.
- The Fund has the flexibility to hold up to 25% unlisted assets should that arise from execution of listed investment value maximization strategy
Reports
The Team
Trustee Board
![Fiona Pak-Poy](/sites/hmc/cache/file/D6899C26-5FE7-4AA6-9880D86E7BF0FD55_square.jpg)
Fiona Pak-Poy
Independent Trustee Director
![Jingmin Qian](/sites/hmc/cache/file/AB017929-B9CF-493A-9FCAFB1D99DC85E0_square.jpg)
Jingmin Qian
Independent Trustee Director
![Dr Chris Roberts AO](/sites/hmc/cache/file/E7F51A0D-C04E-4CC4-B01CE7D0758AE04A_square.jpeg)
Dr Chris Roberts AO
Independent Trustee Director
![David Di Pilla](/sites/hmc/cache/file/C2436496-03B7-487F-81DF825B71BF65C1_square.jpeg)
David Di Pilla
Trustee Director
Investment Committee
![Fiona Pak-Poy](/sites/hmc/cache/file/D6899C26-5FE7-4AA6-9880D86E7BF0FD55_square.jpg)
Fiona Pak-Poy
Independent Trustee Director
![Jingmin Qian](/sites/hmc/cache/file/AB017929-B9CF-493A-9FCAFB1D99DC85E0_square.jpg)
Jingmin Qian
Independent Trustee Director
![Dr Chris Roberts AO](/sites/hmc/cache/file/E7F51A0D-C04E-4CC4-B01CE7D0758AE04A_square.jpeg)
Dr Chris Roberts AO
Independent Trustee Director
![Chris Saxon](/sites/hmc/cache/file/96C618E3-C0C5-46D2-90DE8EFEB3F2D4C1_square.jpeg)
Chris Saxon
Chair HMC Capital
![David Di Pilla](/sites/hmc/cache/file/C2436496-03B7-487F-81DF825B71BF65C1_square.jpeg)
David Di Pilla
Chair of Investment Committee
![Greg Hayes](/sites/hmc/cache/file/04DAE5EF-74DC-482C-84944B8951751235_square.jpeg)
Greg Hayes
Non-Executive Director HMC Capital
Management Team
![David Di Pilla](/sites/hmc/cache/file/C2436496-03B7-487F-81DF825B71BF65C1_square.jpeg)
David Di Pilla
Managing Director and Group Chief Executive Officer
![Victoria Hardie](/sites/hmc/cache/file/83C405D9-284F-47BB-94AD25328380913F_square.jpg)
Victoria Hardie
Managing Director - HMC Capital Partners
![Misha Mohl](/sites/hmc/cache/file/966F0F42-B083-4203-BE46BAE76F795D0A_square.jpeg)
Misha Mohl
Group Head of Strategy and Investor Relations
![Vaughan Anderson](/sites/hmc/cache/file/8A04EE51-2BF9-44AA-AB2B10D0AE0BEB21_square.jpg)
Vaughan Anderson
Risk Management
![Jamie Sun](/sites/hmc/cache/file/8EE1F0C2-E42D-4FD6-9D2C02497B706FA7_square.jpg)
Jamie Sun
Group Corporate Finance Manager
![Jourdon Whitfield-Horesh](/sites/hmc/cache/file/E4A019DB-3307-46A8-849C5E7ABAA28747_square.jpg)
Jourdon Whitfield-Horesh
Senior Associate
Enquiries
Contact us for more information on the fund or how to invest:
Investor Information
1. Link to Automic
If you are a Wholesale Client, you may apply via the general offer link:
https://investor.automic.com.au/#/w/hmccp